ABPWW
Abpro Holdings Inc
NASDAQ · Healthcare · Biotechnology · US
$0.00
+0.00%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
—
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 7, 2025 | Lee Soo Young · director | A-Award | 60,600 | $0.32 |
| Aug 4, 2025 | Suk Jin Wook (Miles) · director, officer: CEO and Chairman | Purchase | 72,035 | $0.28 |
| Jul 29, 2025 | Suk Jin Wook (Miles) · director, officer: CEO and Chairman | A-Award | 500,000 | $0.00 |
| Jul 29, 2025 | Eisenberg Anthony D. · director | A-Award | 60,600 | $0.32 |
| May 19, 2025 | Suk Jin Wook (Miles) · director, officer: CEO and Chairman | Purchase | 16,200 | $0.26 |
| May 1, 2025 | Suk Jin Wook (Miles) · director, officer: CEO and Chairman | Purchase | 4,325 | $0.25 |
| Apr 25, 2025 | Suk Jin Wook (Miles) · director, officer: CEO and Chairman | Purchase | 7,460 | $0.28 |
| Apr 25, 2025 | Suk Jin Wook (Miles) · director, officer: CEO and Chairman | Purchase | 26,542 | $0.34 |
| Nov 25, 2024 | Suk Jin Wook (Miles) · director, officer: Co-CEO & Chairman | A-Award | 613,500 | $1.63 |
| Nov 25, 2024 | Chan Ian · director, 10 percent owner, officer: Chief Executive Officer | A-Award | 6,528,200 | $0.00 |
| Nov 25, 2024 | Chan Ian · director, 10 percent owner, officer: Chief Executive Officer | A-Award | 1,137,200 | $0.00 |
| Nov 25, 2024 | Chan Ian · director, 10 percent owner, officer: Chief Executive Officer | A-Award | 987,400 | $0.00 |
| Nov 25, 2024 | Chan Ian · director, 10 percent owner, officer: Chief Executive Officer | A-Award | 787,300 | $1.63 |
| Nov 25, 2024 | Chan Ian · director, 10 percent owner, officer: Chief Executive Officer | A-Award | 777,100 | $1.67 |
| Nov 25, 2024 | Chan Ian · director, 10 percent owner, officer: Chief Executive Officer | A-Award | 577,500 | $1.73 |
| Nov 15, 2024 | Markelewicz Robert J. Jr. · officer: Chief Medical Officer | A-Award | 40,800 | $1.67 |
| Nov 15, 2024 | Suk Jin Wook (Miles) · director, officer: Co-CEO & Chairman | A-Award | 91,900 | $0.00 |
| Nov 15, 2024 | Markelewicz Robert J. Jr. · officer: Chief Medical Officer | A-Award | 538,600 | $1.73 |
| Nov 15, 2024 | Markelewicz Robert J. Jr. · officer: Chief Medical Officer | A-Award | 74,600 | $1.73 |
| Nov 15, 2024 | Markelewicz Robert J. Jr. · officer: Chief Medical Officer | A-Award | 41,700 | $1.63 |
| Nov 15, 2024 | Markelewicz Robert J. Jr. · officer: Chief Medical Officer | A-Award | 29,800 | $1.63 |
| Nov 15, 2024 | Markelewicz Robert J. Jr. · officer: Chief Medical Officer | A-Award | 24,300 | $1.73 |
| Nov 15, 2024 | Markelewicz Robert J. Jr. · officer: Chief Medical Officer | A-Award | 10,200 | $1.63 |
| May 22, 2008 | POWELL PAUL A · director | A-Award | 666 | $4.50 |
| May 22, 2008 | POWELL PAUL A · director | A-Award | 10,000 | $2.06 |
| May 22, 2008 | LOGUE DENNIS E · director | A-Award | 666 | $4.50 |
| May 22, 2008 | LOGUE DENNIS E · director | A-Award | 10,000 | $4.50 |
| May 22, 2008 | COX RALPH · director | A-Award | 666 | $4.50 |
| May 22, 2008 | COX RALPH · director | A-Award | 10,000 | $4.50 |
| May 22, 2008 | CARTER HAROLD D · director | A-Award | 666 | $4.50 |
Institutional positioning
13F filings over the trailing two quarters
New 0Increased 0Reduced 0Sold out 1
| Filer | Action | Shares | Filed |
|---|---|---|---|
| GOLDMAN SACHS GROUP INC | Unchanged | 179,100 | Mar 25, 2026 |
| GOLDMAN SACHS GROUP INC | Sold Out | 0 | Mar 25, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 7, 2025